Doctors encouraged by early-stage trial of MS stem cell therapy
Injecting stem cells into the brains of multiple sclerosis patients was found to be safe and potentially protective against further damage from the disease.
The therapy reduced inflammation and may have a long-lasting, beneficial impact on patients with secondary progressive MS.
Further research is needed to determine the full potential of this treatment for multiple sclerosis. [ more ]
Doctors encouraged by early-stage trial of MS stem cell therapy
Injecting stem cells into the brains of multiple sclerosis patients was found to be safe and potentially protective against further damage from the disease.
The therapy reduced inflammation and may have a long-lasting, beneficial impact on patients with secondary progressive MS.
Further research is needed to determine the full potential of this treatment for multiple sclerosis. [ more ]
Doctors encouraged by early-stage trial of MS stem cell therapy
Injecting stem cells into the brains of multiple sclerosis patients was found to be safe and potentially protective against further damage from the disease.
The therapy reduced inflammation and may have a long-lasting, beneficial impact on patients with secondary progressive MS.
Further research is needed to determine the full potential of this treatment for multiple sclerosis. [ more ]
Doctors encouraged by early-stage trial of MS stem cell therapy
Injecting stem cells into the brains of multiple sclerosis patients was found to be safe and potentially protective against further damage from the disease.
The therapy reduced inflammation and may have a long-lasting, beneficial impact on patients with secondary progressive MS.
Further research is needed to determine the full potential of this treatment for multiple sclerosis. [ more ]
Doctors encouraged by early-stage trial of MS stem cell therapy
Injecting stem cells into the brains of multiple sclerosis patients was found to be safe and potentially protective against further damage from the disease.
The therapy reduced inflammation and may have a long-lasting, beneficial impact on patients with secondary progressive MS.
Further research is needed to determine the full potential of this treatment for multiple sclerosis. [ more ]
Humans are 8 percent virus - how these ancient invaders still control us today
HERVs, or human endogenous retroviruses, makeup around 8 percent of the human genome, left behind as a result of infections that humanity's primate ancestors suffered millions of years ago.
...
There is still much to learn about the ancient viruses that linger in the human genome, including whether their presence is beneficial and what mechanism drives their activity.Seeing if any of these genes are actually made into proteins will also be important.